Prognostic significance of additional cytogenetic abnormalities and FLT3 mutations in acute promyelocytic leukemia

Leuk Lymphoma. 2014 Jul;55(7):1444-6. doi: 10.3109/10428194.2013.868458. Epub 2014 Jan 28.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Arsenic Trioxide
  • Arsenicals / therapeutic use*
  • Female
  • Humans
  • Karyotype*
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / genetics*
  • Male
  • Mutation*
  • Oxides / therapeutic use*
  • fms-Like Tyrosine Kinase 3 / genetics*

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • fms-Like Tyrosine Kinase 3
  • Arsenic Trioxide